CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,827 · Q2 • database Scopus / SJR & Web of Science indexed
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
New Zealand · Dove Medical Press Ltd
workspace_premium Q2 — Pharmacology visibility_off Single blind Peer Review lock_open Open Access

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is a journal indexed in SJR in Pharmacology and Internal Medicine with an H index of 71. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1762,2 €. The scope of the journal is focused on diabetes, obesity, metabolic syndrome. It has an SJR impact factor of 0,827 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,827.

Publisher: Dove Medical Press Ltd
Category: Pharmacology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,827 Q2
H-index 71
Acceptance rate pie_chart
30% Selective
Source Acceptance_Rate
Time to publication hourglass_top
16 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.762 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,827

H-index

71

Docs (year)

425

Docs 3y

1146

Total refs

18416

Cites 3y

3491

Citable 3y

1114

Cites/Doc 2y

2.85

Ref/Doc

43.33

Immediate OA

1762,2 €

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy?

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy has an SJR of 0,827 (best quartile Q2) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 1762,2 EUR.

What is the acceptance rate?

The acceptance rate recorded for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 30%.